On ECHEMI
Home > Drugs > Yunpeng Pharmaceutical Group Co., Ltd.
Yunpeng Pharmaceutical Group Co., Ltd.
  • Founded in:

    1998-09-15
  • Country:

    China China
  • Address:

    No. 19, Yunpeng Avenue, Pharmaceutical Industrial Park, Xiangfen County, Linfen City, Shanxi Province
  • Tax NO.:

    911410027136140375
  • Registered Funds:

    200 million yuan
  • Website:

  • Email:

Related Drugs
Rifadin Capsules
The main ingredient of this product is Rifadin, and its chemical name is: 3-(4-isobutyl-1-piperazinyl) Rifamycin. Molecular formula: C45H63N3O12 Molecular weight: 837.99
Name Description Content CAS NO. Registered Holders
Rifampicin

The antibacterial spectrum is similar to that of rifampicin. It has good antibacterial activity against tuberculosis and leprosy. When the dosage is 1/3 of that of rifampicin, similar or higher efficacy can be achieved. It has a good effect on Staphylococcus aureus and has certain antibacterial activity against some Escherichia coli. In addition, it also has an inhibitory effect on Chlamydia trachomatis.

More

The antibacterial spectrum is similar to that of rifampicin. It has good antibacterial activity against tuberculosis and leprosy. When the dosage is 1/3 of that of rifampicin, similar or higher efficacy can be achieved. It has a good effect on Staphylococcus aureus and has certain antibacterial activity against some Escherichia coli. In addition, it also has an inhibitory effect on Chlamydia trachomatis.

13292-46-1 24
Mexiletine Hydrochloride
Name Description Content CAS NO. Registered Holders
Mexiletine hydrochloride

Extract from the above information

More

Extract from the above information

5370-01-4 19
Phenytoin Sodium Tablets
The main ingredient of this product is phenytoin sodium, and its chemical name is: 5,5-diphenyl-2,4-imidazolidinedione sodium salt.
Name Description Content CAS NO. Registered Holders
Phenytoin sodium

Antiepileptic drug, antiarrhythmic drug; increases cellular sodium ion outflow, reduces sodium ion inflow, stabilizes nerve cell membrane; shortens action potential interval and effective refractory period, inhibits calcium ion influx, reduces myocardial automaticity; has anti-neuralgia and skeletal muscle relaxation effects; inhibits the synthesis (or) secretion of collagenase by skin fibroblasts; accelerates vitamin D metabolism; has anti-folate effect; has inhibitory effect on the hematopoietic system; can cause allergic reactions; has enzyme induction effect; intravenous administration can dilate peripheral blood vessels.

More

Antiepileptic drug, antiarrhythmic drug; increases cellular sodium ion outflow, reduces sodium ion inflow, stabilizes nerve cell membrane; shortens action potential interval and effective refractory period, inhibits calcium ion influx, reduces myocardial automaticity; has anti-neuralgia and skeletal muscle relaxation effects; inhibits the synthesis (or) secretion of collagenase by skin fibroblasts; accelerates vitamin D metabolism; has anti-folate effect; has inhibitory effect on the hematopoietic system; can cause allergic reactions; has enzyme induction effect; intravenous administration can dilate peripheral blood vessels.

630-93-3 14
Phenytoin Sodium Tablets
The main ingredient of this product is phenytoin sodium, and its chemical name is: 5,5-diphenyl-2,4-imidazolidinedione sodium salt
Name Description Content CAS NO. Registered Holders
Phenytoin sodium

Antiepileptic drugs, antiarrhythmic drugs. The therapeutic dose does not cause sedation and hypnosis, and has a selective antagonistic effect on the tonic phase of super-strong electric shock and convulsion, but is ineffective or even aggravates the spasm phase. Therefore, it is effective for grand mal epileptic seizures, but ineffective for absence seizures. It increases the outflow of sodium ions from cells, reduces the inflow of sodium ions, stabilizes the nerve cell membrane, increases the excitation threshold, and reduces the spread of high-frequency discharges in the lesion. It shortens the action potential interval and the effective refractory period, inhibits the inflow of calcium ions, reduces myocardial autonomy, inhibits the sympathetic center, has an inhibitory effect on the ectopic rhythm points of the atria and ventricles, and increases the thresholds for atrial fibrillation and ventricular fibrillation.

More

Antiepileptic drugs, antiarrhythmic drugs. The therapeutic dose does not cause sedation and hypnosis, and has a selective antagonistic effect on the tonic phase of super-strong electric shock and convulsion, but is ineffective or even aggravates the spasm phase. Therefore, it is effective for grand mal epileptic seizures, but ineffective for absence seizures. It increases the outflow of sodium ions from cells, reduces the inflow of sodium ions, stabilizes the nerve cell membrane, increases the excitation threshold, and reduces the spread of high-frequency discharges in the lesion. It shortens the action potential interval and the effective refractory period, inhibits the inflow of calcium ions, reduces myocardial autonomy, inhibits the sympathetic center, has an inhibitory effect on the ectopic rhythm points of the atria and ventricles, and increases the thresholds for atrial fibrillation and ventricular fibrillation.

630-93-3 14
Cyproheptadine Hydrochloride Tablets
The main ingredient of this product is cyproheptadine hydrochloride, and its auxiliary materials are: glyceryl monostearate, white petrolatum, stearic acid, octadecyl alcohol, liquid paraffin, glycerin, Tween-80, triethanolamine, ethyl hydroxybenzoate.
Name Description Content CAS NO. Registered Holders
CYPROHEPTADINE HYDROCHLORIDE

This product can compete with histamine released from tissues for H2 receptors on effector cells, thereby preventing the onset of allergic reactions and relieving the spasmodic and congestive effects of histamine.

More

This product can compete with histamine released from tissues for H2 receptors on effector cells, thereby preventing the onset of allergic reactions and relieving the spasmodic and congestive effects of histamine.

969-33-5 7
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.